Delving into the Latest Updates on Recombinant human keratinocyte growth factor-2(Guangzhou Jida Gene Pharmacy Engineering Research Center Co Ltd) with Synapse

Overview

Basic Info

Drug Type

Growth factors

Synonyms-

Target

FGFR2

Action

stimulants

Mechanism

FGFR2 stimulants(Fibroblast growth factor receptor 2 stimulants)

Therapeutic Areas

Eye Diseases

Active Indication

Corneal epithelial defect

Inactive Indication

Keratitis

Originator Organization

Guangdong Jidai Gene Drug Eng Research Ctr Co. Ltd.

Active Organization

Guangdong Jidai Gene Drug Eng Research Ctr Co. Ltd.

Wenzhou Medical College

Inactive Organization-

Drug Highest PhasePhase 1

First Approval Date-

Regulation-

Login to view timeline

主要目的：评价在中国健康受试者中单次、多次眼部给予rhKGF-2滴眼液后的局部（眼部）和全身的安全性和耐受性。次要目的：？评价在中国健康受试者中单次、多次眼部给予rhKGF-2滴眼液后的药代动力学（Pharmacokinetics, PK）特征。

[Translation]

Primary objective: To evaluate the local (ocular) and systemic safety and tolerability of rhKGF-2 eye drops after single and multiple ocular administration in healthy Chinese subjects. Secondary objective: To evaluate the pharmacokinetic (PK) characteristics of rhKGF-2 eye drops after single and multiple ocular administration in healthy Chinese subjects.

Start Date-

Sponsor / Collaborator

Guangdong Jidai Gene Drug Eng Research Ctr Co. Ltd.

[+1]

100 Clinical Results associated with Recombinant human keratinocyte growth factor-2(Guangzhou Jida Gene Pharmacy Engineering Research Center Co Ltd)

Login to view more data

100 Translational Medicine associated with Recombinant human keratinocyte growth factor-2(Guangzhou Jida Gene Pharmacy Engineering Research Center Co Ltd)

Login to view more data

100 Patents (Medical) associated with Recombinant human keratinocyte growth factor-2(Guangzhou Jida Gene Pharmacy Engineering Research Center Co Ltd)

Login to view more data

100 Deals associated with Recombinant human keratinocyte growth factor-2(Guangzhou Jida Gene Pharmacy Engineering Research Center Co Ltd)

Login to view more data

R&D Status

10 top R&D records.

Login

to view more data

Indication	Highest Phase	Country/Location	Organization	Date
Corneal epithelial defect	Phase 1	China	Guangdong Jidai Gene Drug Eng Research Ctr Co. Ltd.	10 Mar 2021
Corneal epithelial defect	Phase 1	China	Wenzhou Medical College	10 Mar 2021
Keratitis	IND Application	China	Guangdong Jidai Gene Drug Eng Research Ctr Co. Ltd.	07 Sep 2017
Keratitis	IND Application	China	Wenzhou Medical College	07 Sep 2017

Login to view more data

Clinical Result

Indication

Phase

Evaluation

View All Results

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.

login

or

view full example data

Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.

login

or

view full example data

Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.

login

or

view full example data

Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.

login

or

view full example data

Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.

login

or

view full example data

Accelerate your research with the latest regulatory approval information.

Biosimilar

Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.

login

or

view full example data